ArticleBioinformation2025
Evaluation of salivary lactate dehydrogenase level among tobacco users - A hospital based study.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salivary lactate dehydrogenase (LDH) holds promise as a screening tool for early oral mucosal changes, including precancers and cancers, often linked to tobacco use. This study evaluated salivary LDH levels across 135 patients from the dental outpatient department at M. G. M. Medical College and Hospital, Jamshedpur, Jharkhand, India. Participants were categorized into three groups (n=45 each): non-tobacco users (controls), tobacco users without oral lesions and tobacco users with oral lesions. Unstimulated saliva samples were collected, centrifuged and analyzed for LDH levels. Results revealed significantly highest salivary LDH levels in tobacco users with lesions, followed by tobacco users without lesions and then the control group. These findings suggest that salivary LDH could be a valuable biomarker for detecting pathological changes in the oral mucosa of tobacco users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.